An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome

An Integrated Gut Microbiota and Network Pharmacology Study on Fuzi-Lizhong Pill for Treating Diarrhea-Predominant Irritable Bowel Syndrome

Diarrhea-predominant irritable bowel syndrome (IBS-D) is one of the most common chronic functional gastrointestinal diseases with limited treatments. Gut microbiota play an important role in chronic gastrointestinal diseases. In traditional Chinese medicine (TCM), Spleen–Yang deficiency (SYD) is one...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang Zhen, Lin Xia, Huang You, Zhou Jingwei, Yang Shasha, Wei Xinyi, Lai Wenjing, Zhang Xin, Fu Chaomei
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
irritable bowel syndrome
Fuzi-Lizhong pill
gut microbiota
network pharmacology
crucial targets
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/9fc6e3040d664f43ab91b1d8bf20890e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares